Catalent Biologics Content

  1. Exploring New And Improved Analytical Methods For Traditional And Unique Modalities 1/2/2025

    Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

  2. Using Novel Biological Responses For Robust Cell-Based Potency Assays 12/2/2024

    Ensure the potency and efficacy of your biologic products with a GMP-compliant potency bioassay, offering accurate real-time assessments for GMP release and stability testing.

  3. Biologics Analytical Services 5/14/2024

    With extensive experience and capabilities, we foster a collaborative environment, developing and implementing innovative analytical methods to efficiently address the testing needs of our partners.

  4. High-Throughput Preformulation Development Platform For Biologics 11/21/2019

    A high-throughput formulation development for sample preparation and sample analysis enabled a simple and less labor-intensive screening of a broad range of conditions in considerably less time.

  5. Characterization Of A Therapeutic mAb, Associated Antigen-Binding Fragments 10/9/2019

    Size homogeneity of a mAb in solution is crucial for comparability and characterization. Here, an IgG1 antibody was cleaved into antigen-binding fragments via pepsin and papain digestion, then purified.

  6. High-Throughput Formulation Development For High-Concentration mAbs 6/10/2019

    See how a high-throughput microwell plate platform economically screens a model IgG1 mAb at 120 mg/ml across 96 formulations while minimizing protein use and maximizing data output.

  7. European Center Of Excellence For Clinical Biologics

    Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.

  8. Optimizing Monoclonal Antibody Manufacturing For Commercial Success

    Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

  9. Leveraging Bio-Functional Assays For Charged Variants Characterization

    The heterogeneity of a biologic product has implications for the final therapy's safety and efficacy. Explore challenges associated with charged variants, including mAbs and fusion proteins.